# RISPERIDONE
> **ANDA202386** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2015-01-12
## Drug
- **FDA Application Number:** ANDA202386
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RISPERIDONE
- **Generic name:** RISPERIDONE
- **Active ingredients:** RISPERIDONE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHARTWELL MOLECULAR
- **Manufacturer:** Chartwell RX, LLC
- **First approval:** 2015-01-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202386)
---
*MORVS · CC0 1.0*